Report cover image

Nucleic Acid Amplification Testing

Publisher UnivDatos Market Insights
Published Jul 01, 2025
Length 135 Pages
SKU # Univ20310269

Description

Nucleic Acid Amplification Testing (NAAT) is a laboratory technique of molecular diagnostics serving as a method of detecting the existence of particular genetic material (DNA or RNA) of a pathogen, viruses, bacteria, or other microorganisms. It can be used to amplify small amounts of nucleic acid to detectable levels, then identify the early and accurate diagnosis of infectious diseases, genetic diseases, and some cancer diseases. Examples of common NAAT methods are the Polymerase Chain Reaction (PCR), Isothermal Amplification, and Ligase Chain Reaction.

The Nucleic Acid Amplification Testing market is set to show a growth rate of about 10.58% during the forecast period (2025-2033F). The market for Nucleic Acid Amplification Testing (NAAT) is boosted by the fact that the world has been experiencing an increasing need for accurate, fast, and early diagnosis of infectious diseases, such as COVID-19, HIV, tuberculosis, and STIs. NAAT is versatile because of its high sensitivity and specificity in diagnosis as compared to traditional methods. The efforts made in the field of molecular technologies, increased use of point-of-care testing, enhanced usage in genetic and cancer diagnostics, and increased collaboration and partnership activities also contribute to the growth of the market. For instance, in May 2025, SynOligo Biotechnologies and Lumiphore announced a partnership to provide time-resolved luminescent oligos and assays for the nucleic acid amplification testing market (NAAT). The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications.
  • Based on the technology category, the market is categorized into PCR Tests, INAAT Tests, LCR Tests, and Others. Out of these, the PCR tests currently hold the largest market share in the NAAT market because of their high accuracy and sensitivity, along with popularity in clinical diagnostics. However, Isothermal Nucleic Acid Amplification Technology (INAAT) tests are expected to witness the fastest growth in the coming years, due to the properties of providing results with high speed, without requiring thermal cycling.
  • Based on the application category, the market is categorized into infectious disease testing, oncology testing, genetic testing, and others. Among these, the Infectious disease testing holds the largest share in the NAAT market, because of the extensive global burden expected to be caused by infectious diseases and the potential of NAAT in early diagnosis and outbreak control. However, genetic testing is expected to witness the fastest growth in the coming years, due to the growing trend of personalized medicine, awareness of hereditary diseases, and the overall improvement in the genomic industry.
  • Based on the end-user category, the market is categorized into hospitals and clinics, diagnostic centers, academic and government institutes, and others. Among these, the hospitals and clinics currently hold the largest market share in the NAAT market because of the high numbers of patients, established laboratory infrastructure, and the ability to carry out more intricate laboratory tests themselves. However, diagnostic centers are expected to witness the fastest growth in the coming years due to their improved specialization, rapid turnaround times, and the rising preference by people seeking outpatient diagnostic services.
  • For a better understanding of the adoption of nucleic acid amplification testing, the market is analyzed based on its worldwide adoption in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), and Rest of World. Among these, the North America nucleic acid amplification testing market holds the largest market share due to its advanced healthcare infrastructure, high testing volumes, and strong presence of leading diagnostic companies. However, the Asia-Pacific region is expected to grow significantly in the future, driven by the growing levels of awareness about healthcare and the spread of infectious diseases, as well as the rising number of diagnostic facilities.
  • Some major players running in the market include F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Promega Corporation, Abbott Laboratories, GENOMTEC, Hologic, Inc., Ustar Biotechnologies, and SD Biosensor, Inc.

Table of Contents

135 Pages
1 Market Introduction
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 Research Methodology or Assumption
2.1. Research Process of the Global Nucleic Acid Amplification Testing Market
2.2. Research Methodology of the Global Nucleic Acid Amplification Testing Market
2.3. Respondent Profile
3 Executive Summary
3.1. Industry Synopsis
3.2. Segmental Outlook
3.2.1. Market Growth Intensity
3.3. Regional Outlook
4 Market Dynamics
4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
4.7.1. Merger & Acquisition
4.7.2. Collaboration & Investment Scenario
4.7.3. Industry Insights: Leading Startups and Their Unique Strategies
5 Pricing Analysis
5.1. Regional Pricing Analysis
5.2. Price Influencing Factors
6 Global Nucleic Acid Amplification Testing Market Revenue (USD Mn), 2023-2033F
7 Market Insights By Technology
7.1. Polymerase Chain Reaction (PCR) Tests
7.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
7.3. Ligase Chain Reaction (LCR) Tests
7.4. Others
8 Market Insights By Application
8.1. Infectious Disease Testing
8.2. Oncology Testing
8.3. Genetic Testing
8.4. Others
9 Market Insights By End-User
9.1. Hospitals and Clinics
9.2. Diagnostic Centers
9.3. Academic and Government Institutes
9.4. Others
10 Market Insights By Region
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific
10.4. Rest of World
11 Value Chain Analysis
11.1. Marginal Analysis
11.2. List of Market Participants
12 Competitive Landscape
12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Forces Analysis
13 Company Profiles
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Overview
13.1.2. Key Financials
13.1.3. SWOT Analysis
13.1.4. Product Portfolio
13.1.5. Recent Developments
13.2. Bio-Rad Laboratories
13.3. Agilent Technologies, Inc.
13.4. Thermo Fisher Scientific Inc.
13.5. Promega Corporation
13.6. Abbott Laboratories
13.7. GENOMTEC
13.8. Hologic, Inc.
13.9. Ustar Biotechnologies
13.10. SD Biosensor, Inc.
14 Acronyms & Assumption
15 Annexure

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us